← Browse by Condition
Medical Condition

malignant primary gliomas

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06632236 Phase 1
Recruiting

5G-EMERALD: Amivantamab in Malignant Brain Tumours

Enrollment
12 pts
Location
United Kingdom
Sponsor
Institute of Cancer Research, ...
View Trial →